Biotech and pharma deals put patents, trial data and regulatory files in front of partners who may also be competitors. Ellty, iDeals and ShareVault are our top picks, with Datasite and Box covering large pharma transactions and long-running research collaboration.
A complete transaction data room with AI tools inside it and a list price on the website.
9.2/10Outstanding
Ellty protects sensitive science with per-viewer watermarks, restrictions on printing and downloading, group permissions and a full activity log, the same core controls as iDeals or Datasite. AI features help business development teams work through dense clinical and regulatory documents, and the listed $149/mo price with a 14-day free trial suits partnering processes that start on short notice.
What we liked
Every core diligence control on our checklist: routed Q&A, group permissions, viewer watermarks, print and download blocking, activity log
AI tools and signing are part of the product, not add-ons
Highest usability score in our ranking (9.8), with self-serve setup for admins
Watch out for
Neither SSO nor a public API at our last check
You redact outside the room, since there is no native tool
No native mobile app; reviewers use the mobile browser
A long-established transaction room with heavyweight security credentials and the highest service score in our ranking.
9.1/10Outstanding
iDeals adds ISO 27001, redaction, SSO and an API, which matters when a big pharma partner runs a detailed security review. Its support scores are the best we recorded.
What we liked
ISO 27001 and SOC 2 certified, with GDPR listed
Built-in redaction alongside watermarks and document rights control
Single sign-on and a public API for IT-led deployments
Watch out for
Pricing is quoted, so you cannot model the cost before talking to sales
No native e-signature and no AI features on our checklist
A long-running US deal platform focused on biotech partnering, licensing and intellectual property.
7.7/10Good
ShareVault has a long focus on life sciences and IP licensing, with Q&A, document rights control and SSO. Two-factor login is not on its feature list and it scores lower on usability.
What we liked
Built around biotech partnering, licensing and IP work
SOC 2 report, ISO 27001 certificate and single sign-on
Buyer question log, viewer watermarks and limits on opened files
Watch out for
Everyday usability is its weakest mark (6.8)
Second-factor sign-in, redaction and AI tooling are not listed
An enterprise content platform with strong security and integrations that some teams stretch into a data room.
8.1/10Very good
Box lists HIPAA among its certifications and works well for long-running research sharing. It is not a deal room: no Q&A module and no document rights control.
What we liked
SOC 2 and ISO 27001, plus HIPAA and GDPR support
Single sign-on, a public API and a native phone and tablet app
AI tooling and a built-in signing feature
Watch out for
Buyer questions have no structured log inside the product
Neither redaction nor limits on opened files
Seat-based billing climbs with every internal user
Prices in USD at the entry level; indicative, confirm with the provider.
The partner who might compete
A licensing negotiation is strange from a security point of view. The biotech wants to show enough data to win a deal, while the pharma company reviewing it may run a competing programme. If talks fail, the reviewer walks away knowing a great deal. Watermarking every page with the viewer’s name, restricting printing and downloads on key files, and keeping a full record of who opened what are the practical tools that make that tension manageable.
So we weighted IP and document protection at 35 percent, more than on any other page of this site.
How the picks compare
Provider
Score
Document rights control
Watermarks
Redaction
ISO 27001
Trial
Ellty
9.2
Yes
Yes
No
No (SOC 2, infrastructure)
14 days
iDeals
9.1
Yes
Yes
Yes
Yes
Yes
ShareVault
7.7
Yes
Yes
No
Yes
Yes
Datasite
8.9
Yes
Yes
Yes
Yes
Demo
Box
8.1
No
Yes
No
Yes
Yes
ShareVault ranks third despite a lower overall score than Datasite. Its long specialisation in life sciences and IP licensing counts for more here than broad M&A tooling. Datasite comes into its own on large acquisitions where a bank runs the process. See the ShareVault review and our Ellty review for full details.
A staged release plan
1
Non-confidential tier
Open a folder with the public summary and pipeline overview to everyone on the outreach list.
2
Confidential tier after CDA
Once a confidentiality agreement is signed, give that partner access to the scientific summary, key patent filings and top-line results.
3
Diligence tier for finalists
For partners in final negotiations, open full study reports, manufacturing files and regulatory correspondence, view-only where possible.
4
Review activity before each step
Check the activity log before promoting a partner to the next tier; it shows how seriously they engaged.
Mistakes to avoid
Uploading patient-level data is the serious one. Deal rooms should hold aggregated or de-identified results. If a partner needs more, discuss a separate, governed data-sharing arrangement.
Another is assuming watermarks stop screenshots. They do not stop them, but they make leaks traceable to a named viewer, which deters most people. Combine them with view-only settings on the most sensitive files.
Security reviews from big pharma
Large pharma partners often send a vendor security questionnaire before their team logs in. Have your provider’s SOC 2 report or ISO 27001 certificate ready to share.
Who should look beyond this list
Academic technology transfer offices sharing early research with several potential licensees at once may care more about simple, wide access than about deal controls, and Box can be enough for that stage. Contract research organisations exchanging study files with sponsors over many years usually need a long-term collaboration platform rather than a transaction room. Medical device companies facing regulator submissions should check how each provider handles audit evidence for their quality system. For an acquisition of a biotech by a larger group, the M&A shortlist applies as well.
Budget notes
Ellty lists its entry price at $149/mo, so a six-month partnering process starts around $900. Box charges from $15 per user per month for ongoing collaboration. iDeals, ShareVault and Datasite quote per project. Our pricing guide explains how quotes are built, and the due diligence shortlist covers the review side of a biotech acquisition.
Frequently asked questions
Which data room is best for biotech licensing?
On our scores Ellty, iDeals and ShareVault suit licensing best. All three offer watermarking, document rights control and an activity log. ShareVault has a long focus on IP and life sciences; iDeals adds ISO 27001 and redaction.
Do life sciences data rooms need HIPAA?
Only if the room will hold protected health information, which deal rooms usually avoid by sharing de-identified data. Box lists HIPAA among its certifications. If patient-level data is in scope, take advice before choosing a provider.
How do I protect trial data in a data room?
Use view-only access for the most sensitive files, apply dynamic watermarks, restrict printing, release data in stages and review the activity log before each new stage.
Can partners download documents?
That is your choice per document or folder. Most life sciences teams allow downloads of summaries and keep raw data and key patents view-only.
